alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                                    9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                       9,802,204
<SECURITIES>                                         0
<RECEIVABLES>                                1,987,984
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            11,790,188
<PP&E>                                      92,738,751
<DEPRECIATION>                              42,338,298
<TOTAL-ASSETS>                              62,191,808
<CURRENT-LIABILITIES>                          934,394
<BONDS>                                     23,973,318
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                  37,284,096
<TOTAL-LIABILITY-AND-EQUITY>                62,191,808
<SALES>                                     15,712,736
<TOTAL-REVENUES>                            15,291,049
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            12,562,006
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,320,246
<INCOME-PRETAX>                              1,408,797
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,408,797
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,408,797
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 372 Introduced in House (IH)]

114th CONGRESS
  1st Session
H. RES. 372

  Recognizing the importance of the 2015 Special Olympics World Games 
   hosted by the United States of America in Los Angeles, California.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 23, 2015

 Mr. Becerra submitted the following resolution; which was referred to 
                    the Committee on Foreign Affairs

_______________________________________________________________________

                               RESOLUTION

 
  Recognizing the importance of the 2015 Special Olympics World Games 
   hosted by the United States of America in Los Angeles, California.

Whereas the Special Olympics improves the lives of those with developmental and 
        intellectual disabilities;
Whereas the 2015 Special Olympics World Games will illustrate our Nation's 
        continued commitment to making our society more inclusive;
Whereas the first Special Olympics World Games held in 1968 featured 1,000 
        athletes from 26 States and Canada competing in track and field, 
        swimming, and floor hockey;
Whereas the 2015 World Games will draw 6,500 athletes from 165 countries 
        competing in 25 different sporting events;
Whereas the 2015 World Games will allow courageous athletes from around the 
        world to experience the joy of displaying their talents and abilities;
Whereas the first medals will be awarded on the 25th anniversary of the 
        Americans with Disabilities Act; and
Whereas the 2015 World Games will continue the tradition of bringing health care 
        services to those most in need: Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) recognizes the importance of the Special Olympics World 
        Games to the millions of people with intellectual disabilities 
        and their loved ones;
            (2) supports the efforts of the athletes, coaches, 
        educators, volunteers, leaders, and workers who make the Games 
        possible; and
            (3) celebrates the return of the World Games to the United 
        States and the city of Los Angeles.
                                 <all>
```
Director Compensation Policy

     1.   Non-employee directors will receive an annual cash retainer of $35,000
          for  service  on the board  and  participation  on the three  standing
          committees.  Pursuant to Section 9 of the Amended and Restated  Equity
          Incentive Plan, as amended (the "1995 Plan"),  non-employee  directors
          may  elect to  receive  all or a  portion  of this  retainer  in stock
          options. Committee and sub-committee Chairs receive an additional cash
          retainer of $10,000.

     2.   Non-employee  directors  will  receive  a  specified  amount  for each
          special  committee  served on, as  specified  from time to time by the
          Board of Directors or relevant committee of the Board of Directors.

     3.   Pursuant to Section 9 of the 1995 Plan,  non-employee  directors  will
          receive an annual grant of stock  options and  restricted  stock,  the
          value  and mix of  which  is  determined  each  year by the  Board  of
          Directors, based on providing overall compensation in the range of the
          75th percentile for a selected peer group of companies.  The value for
          fiscal  2006  is  $136,000.  The  directors  can  elect  to  take  the
          restricted stock in the form of stock options at a ratio of 3-to-1.

     4.   Employee  directors  receive  no  additional  compensation  for  their
          service on the Board.
FIRST
AMENDMENT TO SUBLICENSE AGREEMENT


 


THIS
FIRST AMENDMENT TO SUBLICENSE AGREEMENT (“First Amendment”) is entered into on November 8, 2017 (the “Effective
Date”) by and between ORTHOCYTE CORPORATION, a California corporation, having its principal place of business at 1010 Atlantic
Avenue, Suite 102, Alameda, CA 94501 (“OrthoCyte”), BIOTIME, INC., a California corporation, having its principal
place of business at 1010 Atlantic Avenue, Suite 102, Alameda, CA 94501 (“BioTime”, and together with OrthoCyte,
“BioTime”), and AGEX THERAPEUTICS, INC., a Delaware corporation, having its principal place of business at
1010 Atlantic Avenue, Suite 102, Alameda, CA 94501 (“AgeX”).


 


WITNESSETH


 


WHEREAS,
the parties previously entered into a Sublicense Agreement (“Agreement”) on 17 August 2017 and now wish to clarify
the rights granted thereunder;


 


WHEREAS,
AgeX is an Affiliate of BioTime; and


 


NOW
THEREFORE, for and in consideration of the covenants, conditions and undertakings hereinafter set forth, the parties hereby agree
as follows:


 


1. Section
1.3 of the Agreement shall be deleted and replaced in its entirety by:


 


“AgeX
Cellular Product” means any UURF Product that also contains a Therapeutic Cell.


 


2. Capitalized
terms used herein have the same meaning given to them in the Agreement.


 


3. Other
than expressly amended herein, the Agreement remains in full force and effect.


 


4. This
First Amendment may be executed in any number of counterparts.


 


[SIGNATURE
PAGE TO FOLLOW]


 




    	 



    	 



    

 


IN
WITNESS WHEREOF, BioTime and AgeX have executed this Agreement by their respective officers hereunto duly authorized, on the day
and year hereinafter written.


 


	AGEX
    THERAPEUTICS, INC.	 	BIOTIME,
    INC.
	 	 	 	 	 
	By	/s/
    Michael D. West 	 	By	/s/
    Aditya P. Mohanty
	 	Michael
    D. West	 	 	Aditya
    P. Mohanty
	Title	Chief
    Executive Officer	 	Title	Co-Chief
    Executive Officer


 


Acknowledged
and Agreed by:


 


	ORTHOCYTE
    CORPORATION	 
	 	 	 
	By	/s/
    Michael D. West 	 
	 	Michael
    D. West	 
	Title	Chief
    Executive Officer	 


 


[SIGNATURE
PAGE TO THE FIRST AMENDMENT TO THE UURF SUBLICENSE]
<TABLE> <S> <C>

<ARTICLE> 7
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<DEBT-HELD-FOR-SALE>                           372,576
<DEBT-CARRYING-VALUE>                                0
<DEBT-MARKET-VALUE>                                  0
<EQUITIES>                                          52
<MORTGAGE>                                         375
<REAL-ESTATE>                                    2,163
<TOTAL-INVEST>                                 398,782
<CASH>                                           4,165
<RECOVER-REINSURE>                              61,596
<DEFERRED-ACQUISITION>                          21,435
<TOTAL-ASSETS>                                 668,992
<POLICY-LOSSES>                                439,390
<UNEARNED-PREMIUMS>                                  0
<POLICY-OTHER>                                       0
<POLICY-HOLDER-FUNDS>                                0
<NOTES-PAYABLE>                                 26,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        40,646
<OTHER-SE>                                       2,667
<TOTAL-LIABILITY-AND-EQUITY>                   668,992
<PREMIUMS>                                       7,100
<INVESTMENT-INCOME>                             29,516
<INVESTMENT-GAINS>                                 396
<OTHER-INCOME>                                   9,857
<BENEFITS>                                       9,098
<UNDERWRITING-AMORTIZATION>                      3,248
<UNDERWRITING-OTHER>                            12,599
<INCOME-PRETAX>                                  3,262
<INCOME-TAX>                                       617
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,645
<EPS-PRIMARY>                                      .52
<EPS-DILUTED>                                      .47
<RESERVE-OPEN>                                       0
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                      0
<CUMULATIVE-DEFICIENCY>                              0
        

</TABLE>
Exhibit 10.00


                              ASSIGNMENT AGREEMENT
                              --------------------


         THIS ASSIGNMENT AGREEMENT (this "Agreement") made this 1st day of
January, 1998, by and between PhyMatrix Corp., a Delaware corporation
("PhyMatrix"), and CareMatrix of Massachusetts, Inc., a Delaware corporation
("CareMatrix").

                               W I T N E S S E T H
                               -------------------

         WHEREAS, CareMatrix entered into that certain Management Agreement with
PBG Medical Mall SNF, Ltd. ("PBG") dated June 30, 1996 for the management of a
120 bed skilled nursing facility to be located in Palm Beach Gardens, Florida
(the "Management Agreement"); and

         WHEREAS, CareMatrix assigned all of its rights and obligations under
the Management Agreement to PhyMatrix pursuant to an Assignment Agreement dated
July 1, 1996; and

         WHEREAS, PhyMatrix desires to assign its rights and obligations under
the Management Agreement to CareMatrix and CareMatrix desires to assume such
rights and obligations.

         NOW, THEREFORE, in consideration of the payment of Eight Hundred
Thousand ($800,000) Dollars and the premises and the mutual covenants herein
contained, the parties hereto hereby agree as follows:

         1.    PhyMatrix hereby assigns, sets over and transfers unto CareMatrix
               to have and to hold from and after the date hereof, all of the
               right, title and interest of PhyMatrix in, to and under the
               Management Agreement, and CareMatrix hereby accepts the within
               assignment and assumes and agrees with PhyMatrix, to perform and
               comply with and to be bound by all of the terms, covenants,
               agreements, provisions and conditions of the Management Agreement
               on the part of PhyMatrix thereunder to be performed on and after
               the date hereof, in the same manner and with the same force and
               effect as if CareMatrix had originally executed the Management
               Agreement.

         2.    This Agreement (i) shall be binding upon and inure to the benefit
               of the parties hereto and their respective successors and
               assigns, (ii) shall be governed by the laws of the Commonwealth
               of Massachusetts, and (iii) may 


<PAGE>


               not be modified orally, but only by a writing signed by each of
               PhyMatrix and CareMatrix.

         IN WITNESS WHEREOF, the parties hereto have duly executed this
Agreement as of the date and year first above written.

                                               PHYMATRIX CORP.


                                               By: _________________________
                                                   Name:
                                                   Title:


                                               CAREMATRIX OF MASSACHUSETTS, INC.


                                               By: _________________________
                                                   Name:
                                                   Title:
August 14, 2006

27363

#### Echt v. Frost

Reversed
February 25, 2002

23937

#### State v. Rivera

Affirmed
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 356 Introduced in House (IH)]

114th CONGRESS
  1st Session
H. RES. 356

  Expressing support for designation of May 30 as ``National Bartter 
                            Syndrome Day''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              July 9, 2015

 Mr. Ryan of Ohio (for himself and Mr. Joyce) submitted the following 
   resolution; which was referred to the Committee on Oversight and 
                           Government Reform

_______________________________________________________________________

                               RESOLUTION

 
  Expressing support for designation of May 30 as ``National Bartter 
                            Syndrome Day''.

Whereas bartter syndrome is a rare kidney condition that causes an imbalance of 
        potassium, sodium, chloride, and other molecules in the body;
Whereas the antenatal form of bartter syndrome, which begins before birth, is 
        often life-threatening and is characterized by abnormally high levels of 
        amniotic fluid surrounding the affected fetus, premature delivery, and 
        salt loss;
Whereas the classical form of bartter syndrome, which begins in early childhood 
        and tends to be less severe, causes individuals to experience fatigue, 
        muscle weakness, growth delay, and developmental delay;
Whereas bartter syndrome likely affects approximately one per million people 
        worldwide, although the exact prevalence is unknown;
Whereas increased awareness and research of the bartter syndrome will promote 
        accurate and early recognition of the disorder and help families with 
        children suffering from this condition cope with the associated 
        difficulties; and
Whereas May 30 would be an appropriate date to designate as ``National Bartter 
        Syndrome Day'': Now, therefore, be it
    Resolved, That the House of Representatives supports the 
designation of ``National Bartter Syndrome Day''.
                                 <all>
```
EXHIBIT 32.1

           CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,

                       AS ADOPTED PURSUANT TO SECTION 906

                        OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing by Ionatron, Inc. (the "Company") of its Quarterly
Report on Form 10-Q for the quarterly period ended March 31, 2005 (the "Report")
I, Thomas C. Dearmin, Chief Executive and Chief Financial Officer of the Company
certify pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002 that:

      (i)   the Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      (ii)  the information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operation
            of the Company.

This certificate is being made for the exclusive purpose of compliance by the
Chief Executive Officer and Chief Financial Officer of Ionatron, Inc. with the
requirements of Section 906 of the Sarbanes-Oxley Act of 2002, and may not be
used for any other purposes. A signed original of this written statement
required by Section 906 has been provided to Ionatron, Inc. and will be retained
by Ionatron, Inc. and furnished to the Securities and Exchange Commission or its
staff upon request.




                                          /s/ Thomas C. Dearmin
                                          ---------------------------
                                          Thomas C. Dearmin
                                          Chief Executive Officer and
                                          Chief Financial Officer


Date: May 10, 2005
April 28, 2000

23027

#### Rita v. State

Affirmed
1

Daniels, Nia (FAA)

From: Clay, Alan <Alan.Clay@aa.com>

Sent: Monday, January 12, 2015 3:17 PM

To: Daniels, Nia (FAA)

Cc: Riley, Matt; Whitrock, Skip (FAA); Thomas, Ronald

Subject: Retraction of Petition for Exemtion FAA Docket # 2014-1035

Attachments: American_Airlines_-_Exemption_Rulemaking.pdf

Ms. Daniels, 

American Airlines respectful requests that the Petition for Exemption (FAA Docket # 2014-1035) for 121.163 (a) 

(b) and (c) be withdrawn from FAA consideration. I am making this request on behalf of Ronald Thomas 

Managing Director for Flight Operations. 

I’ve attached the original letter of submission requesting the Exemption for reference. Please contact me for 

any questions regarding this request to withdraw the petition. 

Kind regards, 

Alan Clay 

Director Flight Operations Support

Alan.Clay@aa.com Office 817.967.5157 Cell 817.821.9954

NOTICE: This email and any attachments are for the exclusive and confidential use of the intended recipient(s). If you are

not an intended recipient, please do not read, distribute, or take action in reliance upon this message. If you have

received this in error, please notify me immediately by return email and promptly delete this message and its

attachments from your computer.
QUAYSHAUN HEATH,

Petitioner,

v.

STATE OF FLORIDA,

Respondent.

___________________________/

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D17-2411

Opinion filed September 20, 2017.

Petition for Belated Appeal -- Original Jurisdiction.

Quayshaun Heath, pro se, Petitioner.

Pamela Jo Bondi, Attorney General, Tallahassee, for Respondent.

PER CURIAM.

The petition for belated appeal is granted. Petitioner shall be allowed a belated 

appeal from the March 1, 2017, Order Denying Motion for Postconviction Relief in 

Duval County Circuit Court case number 16-2011-CF-8018-AXXX-MA. Upon 

issuance of mandate in this cause, a copy of this opinion shall be provided to the clerk 

of the circuit court for treatment as the notice of appeal. Fla. R. App. P. 

9.141(c)(6)(D).

MAKAR, OSTERHAUS, and WINOKUR, JJ., CONCUR.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Chattem,
Inc.'s audited financial statements and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          NOV-30-1998
<PERIOD-START>                             DEC-01-1997
<PERIOD-END>                               NOV-30-1998
<CASH>                                           2,076
<SECURITIES>                                         0
<RECEIVABLES>                                   37,356
<ALLOWANCES>                                       750
<INVENTORY>                                     19,606
<CURRENT-ASSETS>                                62,096
<PP&E>                                          36,152
<DEPRECIATION>                                  18,006
<TOTAL-ASSETS>                                 369,012
<CURRENT-LIABILITIES>                           61,412
<BONDS>                                        273,913
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,944
<OTHER-SE>                                      22,757
<TOTAL-LIABILITY-AND-EQUITY>                   369,012
<SALES>                                        220,064
<TOTAL-REVENUES>                               220,064
<CGS>                                           60,889
<TOTAL-COSTS>                                  174,845
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              26,676
<INCOME-PRETAX>                                 28,972
<INCOME-TAX>                                    10,844
<INCOME-CONTINUING>                             18,128
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  2,859
<CHANGES>                                            0
<NET-INCOME>                                    15,269
<EPS-PRIMARY>                                     1.63
<EPS-DILUTED>                                     1.57
        

</TABLE>
#### State v. Moses

26529

06/09/2005

Denied

107 Hawai'i 282, 112 P.3d 768
Exhibit 23
 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  Form S-3 Registration No. 333-54722
    
    Form S-8
    Registration No. 33-55083Registration No. 333-54722-01
    
    
    
    Registration No, 33-55083-01Registration No. 333-54722-02
    
    
    
    Registration No. 33-55083-02Registration No. 333-117470
    
    
    
    Registration No. 333-28229Registration No. 333-117470-01
    
    
    
    Registration No. 333-28229-01Registration No. 333-117470-02
    
    
    
    Registration No. 333-28229-02Registration No. 333-72893
    
    
    
    Registration No. 333-55717Registration No. 333-55717-01Registration No. 333-55717-02Registration No. 333-74185Registration No. 333-74185-01Registration No. 333-74185-02Registration No. 333-86041Registration No. 333-86041-01Registration No. 333-86041-02Registration No. 333-37956Registration No, 333-68790Registration No. 333-68790-01Registration No. 333-68790-02Registration No. 333-100682Registration No. 333-100682-01Registration No. 333-100682-02Registration No. 333-103440Registration No. 333-103440-01Registration No. 333-103440-02Registration No. 333-107701Registration No. 333-107701-01Registration No. 333-107701-02Registration No. 333-109869Registration No. 333-109869-01Registration No. 333-109869-02Registration No. 333-110269Registration No. 333-110269-01Registration No. 333-110269-02Registration No. 33-44575
  /s/ ERNST & YOUNG LLP